SatRx LLC works in very close partnership with the best scientist of drug development. It allows us to apply the latest advances in the science and significantly increases the posibility of project success.
Professor of Medicine
Associate Dean for Scientific Affairs, UCSD
Dr. Olefsky serves as Professor of Medicine and Co-Chair, Division of Endocrinology and Metabolism, and Assistant Dean Science and Technology of University of California at San Diego. Dr. Olefsky is the Head of the division of Endocrinology and Metabolism of University of California, San Diego School of Medicine. His major focus for the basic research program is to understand the molecular and cellular mechanisms of insulin and IGF-I action. An important emphasis is placed on understanding the structure/function relationship of the cognate receptors for these ligands. He co-founded Metabolex, Inc. and serves as a Member of Scientific Advisory Board at NGM Biopharmaceuticals, Inc., Sirtris Pharmaceuticals Inc., Biodel Inc. and DiObex Inc. Dr. Olefsky has published more than 350 papers and is on the Editorial Board of Endocrinology and Diabetes. He was the recipient of the ADA's Outstanding Scientific Achievement Award, The Banting and Best Award of the Canadian Diabetes Association, the Edwin Astwood Award of The Endocrine Society, the Elliott P. Joslin Medal, the Mayo Soley Award of the Western Society for Clinical Investigation, and the American Diabetes Associations' Banting Medal for Scientific Achievement.
Dr. Alexandre V. Ivachtchenko is CEO and CSO, Chairman of the Board of Directors and Chairman of Scientific Advisory Board of Alla Chem, LLC. He is the founder of several companies, including ChemDiv, Inc. (1991, USA), IF, Ltd. (1995, Ukraine), Institute of Combinatorial Organic Synthesis of Biologically Active Substances (1998, Ukraine), Chemical Diversity Research Institute (СDRI, 2003, Russia), AllaChem, LLC. (2004, USA), and Avineuro Pharm., Inc. (2008, USA). He sits as the Scientific Supervisor and member of the Board of Directors of ChemDiv, AllaChem, Avineuro, СDRI, Center for High Technology ChimRar (Russia), and other companies.
Professor Ivachtchenko is a world-renown expert in the fields of fine organic synthesis and medicinal chemistry. Under his leadership, a number of novel drug candidates, including those for treatment of cancers, hepatitis C, influenza, Alzheimer’s disease and schizophrenia, were discovered and advanced to clinical studies.
Earlier in his career (1973-1990), Professor Ivachtchenko was engaged in the development of organic materials for electronic devices, including liquid crystals. He held a number of positions of growing responsibilities (up to Laboratory Head) at the Research Institute of Organic Intermediates and Dyes, USSR Ministry of Chemical Ministry (Moscow, 1973-1994), and served as Deputy Geneal Director, Scientific Research Institute of Chemical Reagents and High Purity Chemicals (IREA), USSR Ministry of Chemical Industry (1994-1999).
Professor Ivachtchenko obtained his Diploma (MS equivalent) from St.-Petersburg State Institute of Technology (1968), his Ph.D. from IREA (1973), his Dr. Chem. Sci. (Dr. Habil. equivalent) from the Mendeleyev University of Chemical Technology of Russia (1982), and became Professor in organic chemistry in 1988 (Higher Attestation Commission, USSR Council of Ministry Heads). His dissertation works (Ph.D. & Dr. Chem. Sci.) are made in the specialty “Chemical technology of thin organic synthesis”. He holds a number of honorary titles, including Honored Inventor of Russia (1984), USSR State Prize winner (1983) and the Prize of the USSR Council of Ministry Heads Prize winner (1989). Professor Ivachtchenko is an author of over 500 scientific publications and over 250 patents.
Prof. Petunina is one the leading Russian endocrinologists. She serves as the Head of Endocrinology Department of Faculty of Postgraduate Professional Training of Physicians at I.M. Sechenov First Moscow State Medical University. Prof. Petunina is author and co-author of more than 150 publications in peer-reviewed journals and guidelines for physicians. Her scientific interests include investigation of dipeptidylpeptidase-4 inhibitors in the treatment of type 2 diabetes mellitus. Prof. Petunina is a co-author of Russian National Standard “Endocrinology”.